Mapping Cancer's evolution: a study to outsmart treatment resistance
NCT ID NCT05628376
First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time
Summary
This study follows 600 people with lung cancer or mesothelioma to track how their tumors evolve during and after treatment. Researchers collect blood, tissue, and imaging samples every few months to understand why some cancers come back or stop responding to therapy. The goal is to uncover patterns that could lead to smarter, more personalized treatments in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could reveal why some lung cancers resist treatment or recur, pointing toward better therapies and personalized monitoring strategies.
- What could go wrong
- This is an observational study, not a treatment trial, so it will not directly benefit participants. Results may take years to translate into clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NON-SMALL CELL) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University College London Hospitals NHS Foundation Trust
RECRUITINGLondon, NW1 2PG, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new nucleotide analogue boost cancer treatment?
- Can a Two-Pronged attack shrink Hard-to-Treat cancers?
- Can standard cancer treatment wake up the immune system? a study investigates.
- Experimental drug duo aims to boost immune attack on tough cancers
- Pinpoint radiation may spare the brain in lung cancer that spreads
- Rapid autopsy program aims to unlock secrets of aggressive lung cancer